Home » Newsletters » BioWorld

BioWorld

July 8, 1993

View Archived Issues

IMMUNE RESPONSE REGISTERS SHARES

XYTRONYX RAISES $1.74 MILLION

TRIPLEX COLLABORATES WITH WISTAR RESEARCHER

VESTAR STARTS TRIALS

INTERLEUKIN SAVES MICE

OXFORD COMPLETES FUND-RAISING

GENICA READIES CMT DIAGNOSTIC

TRIALS OF DENTAL COMPOUND APPROVED

OPPOSITION FORMS AGAINST MEDICAID FORMULARIES

EPA REGISTERS ECOGEN BIOPESTICIDE

COLLABORATIVE SELLS TESTING BUSINESS

AGOURON HALTS TRIALS ON DRUG FOR PSORIASIS

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...